Mineralys Therapeutics' blood pressure drug meets goal in trials
10/03/2025 11:08
March 10 (Reuters) - Mineralys Therapeutics MLYS.O said on Monday its blood pressure drug, lorundrostat, met the main goal in late- and mid- stage trials. (Reporting by Kamal Choudhury in Bengaluru; Editing by Sriraj Kalluvila) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway